User profiles for "author:Bruno Crestani"

Bruno Crestani

université paris diderot
Verified email at bch.aphp.fr
Cited by 34852

[HTML][HTML] Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

P Spagnolo, O Distler, CJ Ryerson… - Annals of the …, 2021 - ard.bmj.com
Interstitial lung diseases (ILDs), which can arise from a broad spectrum of distinct
aetiologies, can manifest as a pulmonary complication of an underlying autoimmune and …

[HTML][HTML] Physiology of the lung in idiopathic pulmonary fibrosis

L Plantier, A Cazes, AT Dinh-Xuan… - European …, 2018 - Eur Respiratory Soc
The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple
alterations in lung function. These alterations derive from a complex disease process …

Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature

C Comarmond, B Crestani, A Tazi, B Hervier… - Medicine, 2014 - journals.lww.com
Pulmonary fibrosis (PF) is an uncommon manifestation observed in patients with
antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), particularly …

An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial …

WD Travis, U Costabel, DM Hansell… - American journal of …, 2013 - atsjournals.org
Background: In 2002 the American Thoracic Society/European Respiratory Society
(ATS/ERS) classification of idiopathic interstitial pneumonias (IIPs) defined seven specific …

Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline

G Raghu, M Remy-Jardin, L Richeldi… - American Journal of …, 2022 - atsjournals.org
Background: This American Thoracic Society, European Respiratory Society, Japanese
Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior …

Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis

N Riteau, P Gasse, L Fauconnier… - American journal of …, 2010 - atsjournals.org
Rationale: Pulmonary fibrosis is a devastating as yet untreatable disease. We previously
investigated the endogenous mediators released on lung injury and showed that uric acid is …

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …

AU Wells, KR Flaherty, KK Brown, Y Inoue… - The lancet Respiratory …, 2020 - thelancet.com
Background The INBUILD trial investigated the efficacy and safety of nintedanib versus
placebo in patients with progressive fibrosing interstitial lung diseases (ILDs) other than …

[HTML][HTML] MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

PA Juge, JS Lee, E Ebstein, H Furukawa… - … England Journal of …, 2018 - Mass Medical Soc
Background Given the phenotypic similarities between rheumatoid arthritis (RA)–associated
interstitial lung disease (ILD)(hereafter, RA-ILD) and idiopathic pulmonary fibrosis, we …

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection

J Frija-Masson, MP Debray, M Gilbert… - European …, 2020 - Eur Respiratory Soc
We read with great interest the series of cases reported by Mo et al.[1], describing pulmonary
function after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in …

NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFβ1-induced fibroblast …

N Amara, D Goven, F Prost, R Muloway, B Crestani… - Thorax, 2010 - thorax.bmj.com
Background Persistence of myofibroblasts is believed to contribute to the development of
fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor β1 (TGFβ1) …